DEVELOPMENTAL BIOLOGY OF STREPTOMYCES
链霉菌的发育生物学
基本信息
- 批准号:3125587
- 负责人:
- 金额:$ 9.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1977
- 资助国家:美国
- 起止时间:1977-04-01 至 1990-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Streptomyces are the primary source of medically importnt antibiotics.
This research project is designed at understanding the molecular and
physiological processes involved in sporulation and spore germination of
Streptomyces viridochromogenes and S. griseus. Germinating spores excrete
and degrade intracellular reserves of trehalose and a glutamic acid-rich
protein. Experiments are designed to determine the nature of the reserves
and how the enzymes degrading them are activated during initiation of
germination. Trehalose comprises 25-30% of the dry weight of spores. The
idea that trehalose is involved in desiccation resistance and dormancy of
spores is being studied. Non-sporulating streptomycin non-producing
mutants of S. griseus acquire both properties when supplied a butyrolactone
compound, A-factor, produced by the parent organisms. A-factor induces
formation of NAD-glycohydrolase in the mutants. We will test the
hypothesis that the glycohydrolase modifies sporulation-specific proteins
by an ADP-ribosylatin reaction. ADP-ribosylation of proteins is a major
mechanism of post-translational modificaton in eucaryotes. This work would
be the fist report of this reaction as part of the normal growth and
development of bacteria. There is a possibility that the modification
involves expression of antibiotic synthesis as well as sporulation. We
intend to study the glycohydrolase, clone the gene for its production in
order to study its control, and to identify the proteins modified by the
ADP-ribosylation reaction.
链霉菌是医学上重要的抗生素的主要来源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JERALD C ENSIGN其他文献
JERALD C ENSIGN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JERALD C ENSIGN', 18)}}的其他基金
MOSQUITO TOXIN PRODUCED BY XENORHABDUS SCAPTERISCII
镰状致病杆菌产生的蚊子毒素
- 批准号:
8168950 - 财政年份:2010
- 资助金额:
$ 9.59万 - 项目类别:
MOSQUITO TOXIN PRODUCED BY XENORHABDUS SCAPTERISCII
镰状致病杆菌产生的蚊子毒素
- 批准号:
7954628 - 财政年份:2009
- 资助金额:
$ 9.59万 - 项目类别:
相似国自然基金
CYP450亚类2J2及eposide hydrolase基因变异与新疆哈萨克族及汉族原发性高血压相关性研究
- 批准号:30760216
- 批准年份:2007
- 资助金额:16.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Elucidating the role of peptidyl-tRNA hydrolase activities in translation regulation
阐明肽基-tRNA 水解酶活性在翻译调控中的作用
- 批准号:
2345351 - 财政年份:2024
- 资助金额:
$ 9.59万 - 项目类别:
Standard Grant
The lipid hydrolase NAAA as a target for non-addictive analgesic medications
脂质水解酶 NAAA 作为非成瘾性镇痛药物的靶标
- 批准号:
10584428 - 财政年份:2023
- 资助金额:
$ 9.59万 - 项目类别:
Structural profiling of fungal cell wall polysaccharides using functionally modified glycoside hydrolase
使用功能修饰的糖苷水解酶对真菌细胞壁多糖进行结构分析
- 批准号:
23H02720 - 财政年份:2023
- 资助金额:
$ 9.59万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Implementing a Design-Build-Test pipeline for the Discovery of a Silyl Hydrolase
实施设计-构建-测试流程以发现甲硅烷基水解酶
- 批准号:
2898870 - 财政年份:2023
- 资助金额:
$ 9.59万 - 项目类别:
Studentship
Clinical Phase I trials on an IND single molecule dual inhibitor of Cav3 channels and soluble epoxide hydrolase for treatment of neuropathic pain
Cav3通道和可溶性环氧化物水解酶的单分子双重抑制剂治疗神经性疼痛的IND临床I期试验
- 批准号:
10760089 - 财政年份:2023
- 资助金额:
$ 9.59万 - 项目类别:
Development of soluble epoxide hydrolase inhibitors for the treatment of Alzheimer's disease
开发用于治疗阿尔茨海默病的可溶性环氧化物水解酶抑制剂
- 批准号:
10567257 - 财政年份:2023
- 资助金额:
$ 9.59万 - 项目类别:
Developing a novel treatment of cocaine use disorder using an IND dual inhibitor of Cav3 channel and soluble epoxide hydrolase
使用 Cav3 通道和可溶性环氧化物水解酶的 IND 双重抑制剂开发可卡因使用障碍的新型治疗方法
- 批准号:
10786151 - 财政年份:2023
- 资助金额:
$ 9.59万 - 项目类别:
Long-acting aldicarb hydrolase as a medical countermeasure for aldicarb poisoning
长效涕灭威水解酶作为涕灭威中毒的医学对策
- 批准号:
10724752 - 财政年份:2023
- 资助金额:
$ 9.59万 - 项目类别:
Soluble Epoxide Hydrolase Inhibitor GSK2256294 for Acute Ischemic Stroke
可溶性环氧化物水解酶抑制剂 GSK2256294 用于治疗急性缺血性中风
- 批准号:
10672750 - 财政年份:2023
- 资助金额:
$ 9.59万 - 项目类别:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
使用 T 型钙通道和可溶性环氧化物水解酶的活性 IND 双重抑制剂开发治疗酒精使用障碍的新型药物
- 批准号:
10815882 - 财政年份:2023
- 资助金额:
$ 9.59万 - 项目类别: